BrainsWay (NASDAQ:BWAY – Get Free Report) will be issuing its quarterly earnings data before the market opens on Tuesday, November 12th. Analysts expect the company to announce earnings of $0.01 per share for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link.
BrainsWay Stock Performance
Shares of BrainsWay stock opened at $10.86 on Monday. The company has a market capitalization of $181.12 million, a P/E ratio of 217.20 and a beta of 1.25. The company has a fifty day moving average of $9.06 and a 200 day moving average of $7.35. BrainsWay has a fifty-two week low of $3.78 and a fifty-two week high of $10.89.
Analyst Upgrades and Downgrades
BWAY has been the topic of several research analyst reports. HC Wainwright reiterated a “buy” rating and issued a $16.00 price target on shares of BrainsWay in a research note on Monday, October 21st. Northland Securities upped their target price on shares of BrainsWay from $11.00 to $12.50 and gave the company an “outperform” rating in a research report on Thursday, October 3rd.
BrainsWay Company Profile
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases.
Featured Articles
- Five stocks we like better than BrainsWay
- What Are Dividend Contenders? Investing in Dividend Contenders
- California Resources Stock Could Be a Huge Long-Term Winner
- Basic Materials Stocks Investing
- Observability Wars: Datadog and Dynatrace Vie for Data Dominance
- The Basics of Support and Resistance
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
Receive News & Ratings for BrainsWay Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BrainsWay and related companies with MarketBeat.com's FREE daily email newsletter.